NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/08/2025
Voltar para busca
Dado oficial do USPTO
LACTOFIT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
26/08/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
25/06/2024
Data de registro
26/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/08/2025
Última transação
26/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
3
Tipo de titular
03
Localização do titular
CHUNGCHEONGNAM-DO, KR
Examinador
MARTIN, LIEF
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the first part of the literal element "LACTO" in plain black capital letters and the remaining part of the literal element "FIT" featured in white capital letters within a solid red circle.
Titulares e representantes
Titulares
CHONG KUN DANG HEALTHCARE CORP.
Representantes
Miriam D. Trudell Davis Graham & Stubbs LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Nutraceutical preparations consisting primarily of mixed lactic acid bacteria for use as a dietary supplement; nutraceutical preparations consisting primarily of lactobacilli for use as a dietary supplement; nutraceutical preparations consisting primarily of maltodextrin for use as a dietary supplement; nutraceutical preparations consisting primarily of galacto oligosaccharide for use as a dietary supplement; nutraceutical preparations consisting primarily of fructo-oligosaccharide for use as a dietary supplement; pharmaceutical preparations for health carefor the prevention and treatment of cancerkidney diseaseshypercholesteremiahyperlipidemiaeye diseases and conditionsskin disordershypertensioninfectious diseasesgoutbone fracturesallergic rhinitis and asthmaautoimmune diseases; nutraceutical preparations mainly based on egg for use as a dietary supplement; nutraceutical preparations consisting primarily of beans for use as a dietary supplement; food supplements; powdered nutritional supplement drink mixes; vitamin and mineral food supplements; dietary supplements; nutraceuticals for use as dietary supplements; food supplements consisting of amino acidsminerals and trace elements; lactose for pharmaceutical purposes; milk sugar for pharmaceutical purposes; nutraceutical preparations consisting primarily of fish and shellfish for use as a dietary supplement; nutraceutical preparations consisting primarily of lactic acid bacteria for use as a dietary supplement; dietary and nutritionally fortified food productsdietetic foods and beverages adapted for medical purposes; nutraceutical preparations for use as a dietary supplement for therapeutic or medical purposes; probiotic supplements; nutraceutical preparations consisting primarily of probiotics for use as a dietary supplement; nutraceutical preparations consisting primarily of prebiotics for use as a dietary supplement; anti-oxidant food supplements; nutraceutical preparations consisting primarily of seaweeds for use as a dietary supplement; milk powders being foodstuff for babies; calcium supplements; pharmaceutical drugs for the prevention and treatment of cancerkidney diseaseshypercholesteremiahyperlipidemiaeye diseases and conditionsskin disordershypertensioninfectious diseasesgoutbone fracturesallergic rhinitis and asthmaautoimmune diseases; medicines for human purposes for the prevention and treatment of cancerkidney diseaseshypercholesteremiahyperlipidemiaeye diseases and conditionsskin disordershypertensioninfectious diseasesgoutbone fracturesallergic rhinitis and asthmaautoimmune diseases; medicated food supplements; medical and surgical plasters; pre-moistened medicated tissues; mothproof paper; dietary supplements mainly based on mixed lactic acid bacteria; dietary supplements mainly based on lactic acid bacteria; dietary supplements mainly based on prebiotics extracted from milk products; dietary supplements mainly based on lactobacilli extracted from lactic acid bacteria; dietary supplements mainly based on indigestible maltodextrin extracted from fruits and vegetables; dietary supplements mainly based on fruits and vegetables; dietary supplements mainly based on mineral and vitamin extracted from fruits and vegetables; dietary supplements mainly based on egg; dietary supplements mainly based on fish and shellfish; dietary food supplements made principally of lactic acid bacteria or lactic acid bacteria powder; dietary supplements mainly based on probiotics extracted from milk products; dietary supplements mainly based on vegetables; dietary supplements mainly based on mineral and vitamin extracted from vegetables; dietary supplements mainly based on seaweeds; dietary supplements mainly based on processed beansfoodstuffs excluding bean curds and foodstuffs made from bean curds; dietary supplements mainly based on soya beans; dietary supplements mainly based on probiotics extracted from cereals; dietary supplements mainly based on prebiotics extracted from cereals; dietary supplements mainly based on cereals; dietary supplements made principally of green tea extracts; dietary supplements made principally of pure tea extracts; dietary supplements mainly based on soya bean paste; dietary supplements mainly based on maltose for food; dietary supplements mainly based on wheat germ for human consumption; dietary supplements mainly based on glucose for food; dietary supplements mainly based on oligosaccharides; dietary supplements mainly based on fructo-oligosaccharide; dietary supplements mainly based on xylo-oligosaccharides; dietary supplements mainly based on galacto oligosaccharide; dietary supplements mainly based on tea leaves; dietary supplements mainly based on leaven; healthy drinksbeing dietary supplement beveragesconsisting primarily of probiotics for non-medical use; healthy drinkbeing dietary supplement beveragesconsisting primarily of prebiotics for non-medical use; functional beveragesnutraceutical drinks for use against hangovernot for medical purposes; drinks containing amino acid for use as a nutritional supplement; deer antler extracts for beverages for use as a nutritional supplement; vegetable extracts for use as a nutritional supplement added to beverages; ginseng extracts for use as a nutritional supplement added to beverages; red ginseng extracts for use as a nutritional supplement added to beverages; mixed lactic acid bacteria powdersbeing dietary supplements; lactic acid bacteria powdersbeing dietary supplements; lactic acid bacteria drinksbeing dietary supplements; dietary supplements mainly based on meat
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
26/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/06/2025
PUBO
PUBLISHED FOR OPPOSITION
10/06/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/06/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/04/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/01/2025
GNRT
NON-FINAL ACTION E-MAILED
21/01/2025
CNRT
NON-FINAL ACTION WRITTEN
21/01/2025
DOCK
ASSIGNED TO EXAMINER
21/01/2025
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
18/01/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/11/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/11/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/11/2024
NWAP
NEW APPLICATION ENTERED
26/06/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LACTOFIT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.